Nike Earnings Preview: Great Brand, Bad Investment?

Chapter 01

The contradiction: 87% upside vs a selling C-suite

The TipRanks aggregate calls Nike a "Strong Buy" with a $76 average price target — 87% above the $40.75 stock. But five analysts downgraded since April, Yahoo recommendations show 23 holds vs 13 buys, and insiders sold $2.85M net in the weeks before the print.

Start with the number that stops the scroll: $76.36. That is the average analyst price target on Nike — 87% above the current stock price of $40.75. The TipRanks consensus labels it a "Strong Buy." Sixteen analysts say buy, seven say hold, zero say sell. On paper, this is the most upside in the large-cap consumer sector. Now look at what those same analysts have actually been doing. Since April 1, five analysts have downgraded Nike. Zero have upgraded. Goldman Sachs cut its price target from $76 to $52 — a $24 reduction. RBC Capital cut its target from $70 to $50 — a $20 reduction, and downgraded the stock to Sector Perform. Wells Fargo cut from $55 to $45. The Yahoo recommendation trend tells the same story: three months ago, 24 analysts said buy and 13 said hold. Today, 13 say buy and 23 say hold. The buys nearly halved. The holds nearly doubled. The "Strong Buy" label has not caught up to the individual actions. And while analysts were quietly retreating, Nike's own executives were heading for the door. The Chief Innovation Officer sold $803,000 on June 12. The Chief Operating Officer sold $440,000 on June 10. Executive Chairman Mark Parker — the former CEO — sold 22,230 shares in May. Net insider selling is minus $2.85 million in the weeks before the print. One side of this trade is wrong about Nike. Tuesday decides which.

"The buys nearly halved. The holds nearly doubled. The Strong Buy label has not caught up."

Chapter 03

The insider tape: C-suite sold before the print

Nike's Chief Innovation Officer, COO, and Executive Chairman all sold shares in the weeks before Tuesday's earnings. Net insider selling is −$2.85M. The signal is bearish.

Insider selling is not always meaningful — executives sell for many reasons, including pre-planned 10b5-1 programs. But the pattern here is specific enough to warrant attention. On June 10, two C-suite officers sold in the same 48-hour window: Chief Operating Officer Venkatesh Alagirisamy sold 9,853 shares for $439,936, and Chief Innovation, Product & Design Officer Philip McCartney sold 9,836 shares for $439,177. Two days later, on June 12, McCartney sold again — 17,398 shares for $803,440. In May, Executive Chairman Mark Parker — the CEO who built Nike into what it is — sold 22,230 shares. The total: 26 transactions, 12 buys, 14 sells, net value minus $2.85 million. The signal flag is bearish. What makes this notable is the timing: three weeks before the Q4 print, the people with the best visibility into Nike's operational performance are reducing exposure. They may know something the aggregate consensus does not. Or they may simply be diversifying. But when the Chief Innovation Officer — the executive responsible for the product pipeline that the "Win Now" turnaround depends on — sells twice in 48 hours, it is worth marking.

"The people with the best visibility into Nike's operational performance are reducing exposure three weeks before the print."

Chapter 05

What Tuesday decides: the Q1 guide matters more than the Q4 beat

Nike's Q4 revenue guidance is −2% to −4% YoY. The Q1 FY2027 consensus is $11.5B. A Q4 beat won't move the stock if Q1 guidance falls below consensus. China is expected to show a ~20% decline.

The market has already priced in a weak Q4. Revenue guidance is down 2% to 4% year-over-year, with China as the primary drag — expected to show a 20% decline. The Q4 EPS estimate is just $0.13, down 10% from the prior year. Eighteen analysts have already cut their estimates. The bar is on the floor. What moves the stock Tuesday is not the Q4 headline — it is the Q1 FY2027 guidance. The consensus revenue estimate for Q1 is $11.5 billion. If Nike guides below that, the stock falls regardless of whether Q4 beat or missed. If Nike guides in-line or above, the relief rally could be sharp from oversold conditions — the stock is down 12% in the last month and trading near its 52-week low. There is one potential positive surprise: Nike confirmed that Q4 results will include a one-time tariff refund benefit. If that pushes Q4 revenue above the high end of guidance, it could create a brief optical beat — but the market will look through it to the underlying trajectory. Also watch for commentary on the new CFO transition: David Denton (formerly of Pfizer, Lowe's, and CVS Health) starts August 17. The current CFO, Matthew Friend, will present his last earnings call. Whether he provides forward guidance or defers to the incoming CFO will signal how much visibility Nike has into the next quarter.